<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss xmlns:ev="http://purl.org/rss/1.0/modules/event/" version="2.0">
    
    <channel>
      <title>Novavax Investor Relations</title>
      <link>https://ir.novavax.com/</link>
      <description/>
                  <item>
        <title>Novavax to Participate in September Investor Conferences</title>
        <link>https://novavax.investorroom.com/2026-09-02-Novavax-to-Participate-in-September-Investor-Conferences</link>
        <description>&lt;p&gt;Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conferences: 2026 Cantor Global Healthcare Conference, New York Fireside...&lt;/p&gt;</description>
        <pubDate>09/02/2026</pubDate>
        <guid>https://novavax.investorroom.com/2026-09-02-Novavax-to-Participate-in-September-Investor-Conferences</guid>
      </item>
            <item>
        <title>Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research &amp; Development</title>
        <link>https://novavax.investorroom.com/2026-03-30-Novavax-Appoints-Dr-Robert-Walker-as-Executive-Vice-President-and-Head-of-Research-Development</link>
        <description>&lt;p&gt;Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical Officer Dr. Walker will continue advancing Novavax's R&amp;D efforts...&lt;/p&gt;</description>
        <pubDate>03/30/2026</pubDate>
        <guid>https://novavax.investorroom.com/2026-03-30-Novavax-Appoints-Dr-Robert-Walker-as-Executive-Vice-President-and-Head-of-Research-Development</guid>
      </item>
            <item>
        <title>Novavax to Report First Quarter 2025 Financial Results on May 8, 2025</title>
        <link>https://novavax.investorroom.com/2025-05-01-Novavax-to-Report-First-Quarter-2025-Financial-Results-on-May-8,-2025</link>
        <description>&lt;p&gt;Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, May 8, 2025. Details of...&lt;/p&gt;</description>
        <pubDate>05/01/2025</pubDate>
        <guid>https://novavax.investorroom.com/2025-05-01-Novavax-to-Report-First-Quarter-2025-Financial-Results-on-May-8,-2025</guid>
      </item>
            <item>
        <title>Novavax to Participate in Upcoming September Conferences</title>
        <link>https://novavax.investorroom.com/2023-09-08-Novavax-to-Participate-in-Upcoming-September-Conferences</link>
        <description>&lt;p&gt;Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M&#x2122; adjuvant, today announced that it will participate in two upcoming investor conferences....&lt;/p&gt;</description>
        <pubDate>09/08/2023</pubDate>
        <guid>https://novavax.investorroom.com/2023-09-08-Novavax-to-Participate-in-Upcoming-September-Conferences</guid>
      </item>
            <item>
        <title>Novavax to Participate in the Jefferies Global Healthcare Conference</title>
        <link>https://novavax.investorroom.com/2023-06-01-Novavax-to-Participate-in-the-Jefferies-Global-Healthcare-Conference</link>
        <description>&lt;p&gt;Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M&#x2122; adjuvant, today announced that it will participate in the Jefferies Global Healthcare...&lt;/p&gt;</description>
        <pubDate>06/01/2023</pubDate>
        <guid>https://novavax.investorroom.com/2023-06-01-Novavax-to-Participate-in-the-Jefferies-Global-Healthcare-Conference</guid>
      </item>
                </channel>
  </rss>
